Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

Catherine G. Ambrose, Medical School (MS), Evaluation of Biodegradable Microspheres Impregnated with ABC, Zimmer, $209,433.

Ben J. Barnett, MS, A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Study of Orally Administered SP01A as Monotherapy Treatment of HIV-Infected Patients, Samaritan Pharmaceuticals Inc., $45,565.

Wenyaw Chan, School of Public Health (SPH), A Pilot Geospatial Analysis of Exposure to Air Pollutants and Hospital Admissions in Harris County, Texas, Baylor College of Medicine, $16,598.

Raymond J. Grill, MS and Graduate School of Biomedical Sciences (GSBS), Spatial and Temporal Blood-Spinal Cord-Barrier Dysfunction in Chronic Spinal Cord Injury, The Institute for Rehabilitation and Research, $106,500.

Barry D. Kahan, MS and GSBS, A 24-Month, Multi-Center, Randomized, Open Label Non-Inferiority Study of Efficacy and Safety Comparing Concentration-Controlled Certican in Two Doses (1.5 and 3.0 Mg/Day Starting Doses) with Reduced Neoral Versus 1.44 Mg Myfortic with Standard Dose Neoral, Novartis Pharmaceuticals Corp., $160,294.

Susan Landry, MS, Early Childhood School Readiness Program: Texas Early Education Model (TEEM), Texas Education Agency, $7,275,000; and TEEM Classroom Expansion, Michael and Susan Dell Foundation, $2,000,000.

Jary M. Lesser, MS, A Double-Blind Placebo-Controlled Study of VP4896 for the Treatment of Mild-to-Moderate Alzheimer’s Disease, Quintiles Inc., $213,571.

Zuber D. Mulla, SPH, Morbidity Monitoring Project, Texas Department of State Health Services, $60,106.

Bhamidipati Murthy, MS, Study to Assess the Safety of Epoetin Alfa Manufactured by a Deep Tank Technology, Amgen Inc., $108,485.

Luis Ostrosky-Zeichner, MS, Prognostic Value and Relationship to Microbial and Clinical Outcome of B-Glucan, Associates of Cape Cod Inc., $91,945.

Karen Adler Storthz, Dental Branch and GSBS, Optical Systems for In Vivo Molecular Imaging of Cancer, Rice University, $72,658; and In Vivo Molecular Imaging of Human Papillomavirus, Rice University, $94,909.

Heinrich Taegtmeyer, MS and GSBS, The Molecular LVAD - A Critical Role for Calpains, St. Luke’s Episcopal Hospital, $50,000.

Mary M. Velasquez, MS, The Georgia-Texas Improving Brief Intervention Project, Mercer University School of Medicine, $71,377.

Robert Joseph Yetman, MS, A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Medi-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV) in Children with Hemodynamically Significant Congenital Heart Disease, PPD Development, LP, $34,350.

Renewal

Fernando R. Cabral, MS and GSBS, Tubulin Mutations and Paclitaxel Resistance, National Institutes of Health, $1,061,850.

Kimberly Napoli Eaton, MS, Demonstration of the Safe and Effective Use of LC-MS/MS for the Quantification of Immunosuppressive Drugs from Physiological Fluids,Waters Technologies Corporation, $100,848.